InvestorsHub Logo
Followers 85
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: biopharm post# 150000

Wednesday, 05/14/2014 1:39:58 AM

Wednesday, May 14, 2014 1:39:58 AM

Post# of 346339
Accelerated Approval I say is likely - start at line 525 page 20

http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM358301.pdf

.... and all the pre-clinical collaborations that are going on with companies such as Ambit just may bring some BTD's Peregrines way, since BTD's can be based solely on pre-clinical data. Its been at about 5 months now that Peregrine has been in collaborations with Ambit so data could be coming any day.


"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News